This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

8 Stocks Rising on Unusual Volume

Stocks in this article: ABX SODA DMND LGND SLXP IPHS

Salix Pharmaceuticals

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Salix Pharmaceuticals (SLXP - Get Report) is a pharmaceutical company engaged in acquiring, developing and commercializing prescription drugs used in the treatment of a variety of gastrointestinal disorders, which are those affecting the digestive tract This stock is trading up 7.6% at $37.30 in recent trading.

Today's Volume: 1,044,000

Average Volume: 949,841

Volume % Change: 165%

This stock is spiking higher today after the company said it turned a profit in the third quarter on rising sales of its drug Xifaxan, used to treat diarrhea and certain neurological problems. Salix also agreed to buy privately held Oceana Therapeutics for $300 million in cash.

From a technical standpoint, this stock has trigged a major breakout today now that shares have started to move above some near-term overhead resistance at $35.38. The next major resistance level that traders should watch is at $38.23. A high-volume move above $38.23 should set this stock up to ret-test its July high of $41.50.

Ligand Pharmaceuticals

Ligand Pharmaceuticals (LGND - Get Report) is a biotechnology company that focuses on drug discovery and early-stage development of pharmaceuticals that address critical unmet medical needs. The stock is trading up 2.9% at $12.31 in recent trading

Today's Volume: 204,000

Average Volume: 202,152

Volume % Change: 132%

From a technical standpoint, this stock is starting to move higher today in the face of massive market declines on solid volume. Shares of LGND plunged on Tuesday from close to $16 to just under $12 a share on high volume. The stock has some previous support worth noting at $11.50, and after that big drop yesterday, shares never violated its 200-day moving average of $11.68.

>>10 Most Shorted Stocks in Biotech

Traders should put LGND on their radar for an oversold rebound play since the current relative strength index is showing a reading of 36, which is oversold. Look to use the 200-day as mental stop area in case the stock isn't done going down.

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

3 of 5

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,416.85 +225.48 1.31%
S&P 500 2,021.36 +19.20 0.96%
NASDAQ 4,681.9420 +43.9480 0.95%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs